CA Stock MarketDetailed Quotes
WBIO WPD Pharmaceuticals Inc
- 0.010
- -0.005-33.33%
15min DelayMarket Closed Jul 5 12:29 ET
1.15MMarket Cap0.00P/E (TTM)
0.010High0.010Low30.00KVolume0.010Open0.015Pre Close300.00Turnover0.03552wk High0.03%Turnover Ratio114.82MShares0.00552wk Low--EPS TTM1.12MFloat Cap2.250Historical High0.33P/E (Static)111.97MShs Float0.005Historical Low0.03EPS LYR0.00%Amplitude--Dividend TTM-1.67P/B1Lot Size--Div YieldTTM
WPD Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 269.08%140.14K | -92.47%66.11K | -89.22%80.51K | -93.86%37.97K | 2.33M | 85.68K | -27.31%878.04K | -45.26%746.9K | -72.21%618.61K | -23.92%1.21M |
| Selling and administrative expenses | 198.55%93.3K | -92.72%62.3K | -89.93%73.06K | -94.56%31.25K | --2.21M | --52.23K | 9.68%855.19K | 5.72%725.45K | -42.22%574.33K | -46.97%779.72K |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -48.72%22.51K |
| -General and administrative expense | 198.55%93.3K | -92.72%62.3K | -89.93%73.06K | -94.56%31.25K | --2.21M | --52.23K | 12.94%855.19K | 7.17%725.45K | -39.92%574.33K | -46.92%757.2K |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --159.91K |
| Depreciation amortization depletion | --2.71K | -58.87%3.51K | --0 | --0 | --24.44K | --6.24K | -90.70%8.53K | -93.74%5.54K | -95.46%4.13K | 258.88%91.78K |
| -Depreciation and amortization | --2.71K | -58.87%3.51K | --0 | --0 | --24.44K | --6.24K | -90.70%8.53K | -93.74%5.54K | -95.46%4.13K | 258.88%91.78K |
| Other taxes | ---- | --0 | --0 | ---- | --18.78K | --3.23K | -94.12%2.96K | -88.34%2.42K | -15.05%10.18K | 1,614.28%50.31K |
| Other operating expenses | 556.92%44.13K | -97.36%300 | -44.78%7.45K | -77.59%6.72K | --78.81K | --23.97K | -90.99%11.36K | -68.89%13.5K | -75.23%29.98K | 42.37%126.15K |
| Operating profit | -269.08%-140.14K | 92.47%-66.11K | 89.22%-80.51K | 93.86%-37.97K | -2.33M | -85.68K | 27.31%-878.04K | 45.26%-746.9K | 72.21%-618.61K | 23.92%-1.21M |
| Net non-operating interest income (expenses) | -15.37K | 63.09%-17.83K | 89.63%-4.99K | 0 | -167.52K | -30.15K | -581.01%-48.3K | -4,964.00%-48.11K | -926.85%-40.96K | -177.68%-7.09K |
| Non-operating interest expense | --15.37K | -63.09%17.83K | -89.63%4.99K | --0 | --167.52K | --30.15K | 581.01%48.3K | 4,964.00%48.11K | 926.85%40.96K | 177.68%7.09K |
| Other net income (expenses) | -2.11K | -1,926.67%-1.92K | 137.71%6.85K | 6.35M | 6.28M | -99.98%105 | -112.96%-18.16K | -91.81%87.94K | 54.55%507.34K | |
| Gain on sale of security | ---2.11K | 77.85%-1.92K | 83.25%6.85K | ---- | ---11.51K | --12.67K | -5,486.45%-8.66K | 315.39%3.74K | -1,481.21%-19.25K | -121.17%-155 |
| Special income (charges) | ---- | --0 | --0 | ---- | ---30.1K | ---11.83K | --3.11K | ---21.01K | ---365 | ---- |
| -Less:Impairment of capital assets | ---- | --0 | --0 | ---- | --30.1K | --11.83K | ---3.11K | --21.01K | --365 | ---- |
| -Less:Write off | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | --1.87M | --1.76M | -98.89%5.66K | -100.63%-887 | -89.97%107.56K | 54.95%507.49K |
| Income before tax | -315.11%-157.62K | 90.73%-85.85K | 90.33%-78.65K | 93.36%-37.97K | 3.86M | 6.17M | -30.89%-926.23K | 33.63%-813.17K | 50.54%-571.63K | 43.92%-707.63K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -315.11%-157.62K | 90.73%-85.85K | 90.33%-78.65K | 93.36%-37.97K | 3.86M | 6.17M | -30.89%-926.23K | 33.63%-813.17K | 50.54%-571.63K | 43.92%-707.63K |
| Net income continuous operations | -315.11%-157.62K | 90.73%-85.85K | 90.33%-78.65K | 93.36%-37.97K | --3.86M | --6.17M | -30.89%-926.23K | 33.63%-813.17K | 50.54%-571.63K | 43.92%-707.63K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -315.11%-157.62K | 90.73%-85.85K | 90.33%-78.65K | 93.36%-37.97K | 3.86M | 6.17M | -30.89%-926.23K | 33.63%-813.17K | 50.54%-571.63K | 43.92%-707.63K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -315.11%-157.62K | 90.73%-85.85K | 90.33%-78.65K | 93.36%-37.97K | 3.86M | 6.17M | -30.89%-926.23K | 33.63%-813.17K | 50.54%-571.63K | 43.92%-707.63K |
| Diluted earnings per share | -314.63%-0.0014 | 92.43%-0.0008 | 93.07%-0.0007 | 96.65%-0.0003 | 0.03 | 0.05 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 |
| Basic earnings per share | -314.63%-0.0014 | 92.43%-0.0008 | 93.07%-0.0007 | 96.65%-0.0003 | 0.03 | 0.05 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg